Healthsonix Inc. DL-,001
13.10.06 16:12
#30
BoMa
och das spielt hier
eine äußerst untergeordnete Rolle... es sei denn, Du meinst die Potenz Deines Depots !!!
13.10.06 17:03
#33
BoMa
buran gg
Ich hoffe wirklich, daß Du Montag DAZUstößt *gg* - denn Du wirst das ja nur machen, wenn der Kurs weiter gestiegen ist... und ich will mehr verdienen als 17 % .-))
13.10.06 17:06
#34
Matzelbub
buran
pass mal auf, dass Du noch zum Stoss kommst am Montag und nicht vorher Dein Pulver verschiesst :-)).
13.10.06 17:35
#42
buran
schön und gut
wir sehen ja alle was wir schon hatten
und fundamental??????????????????????
...könnte!!..aber auch nur heisse Luft geblasen werden...
und fundamental??????????????????????
...könnte!!..aber auch nur heisse Luft geblasen werden...
13.10.06 17:35
#43
Matzelbub
BoMi
Du Aktienluder - hast wohl einen Top-Zeitpunkt zum Einstieg erwischt :-)). Aber wir werden wohl hier beide schöne Prozente einfahren können, auch wenn ich dem Ganzen noch nicht traue....
13.10.06 17:45
#46
BoMa
mal was zur Info,
allerdings schon von Ende September, aber egal.
HealthSonix Inc. (OTC: HSXI) has been rated "Outperform" with a target price of $4.22 by Beacon Equity Senior Research Analyst, Shailesh Dhuri, CFA.
Anyone interested in receiving alerts regarding HealthSonix Inc. research should email members@beaconequityresearch.com with "HSXI" in the subject line.
In the report, Mr. Dhuri writes, "The Company has also developed a novel treatment method that combines sound pressure waves with low impact exercises in warm water pools to treat arthritis patients. The treatment, called AquaSonix Therapy, helps to reduce and, in some cases, eliminate arthritis pain and restore flexibility. AquaSonix Therapy, claimed to be a breakthrough in the relevant field of medical treatments, is undergoing additional clinical research trials to provide clinical evidence for expanded medical claims.
"Given the projected high growth in patient base, huge market size in the U.S. and definitive advantages enjoyed by the products and services offered by the Company, HealthSonix appears to have a favorable market environment, required to build a successful business upon."
Beacon Equity Research Disclosure
The management and analysts contributing to this report do not currently hold any shares of HealthSonix Inc. (HSXI), though they may make open market purchases after this report has been issued. Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research ("Beacon") certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Beacon Research has been directly compensated eighteen thousand dollars directly from HealthSonix Inc. for an enrollment in its research program. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.
HealthSonix Inc. (OTC: HSXI) has been rated "Outperform" with a target price of $4.22 by Beacon Equity Senior Research Analyst, Shailesh Dhuri, CFA.
Anyone interested in receiving alerts regarding HealthSonix Inc. research should email members@beaconequityresearch.com with "HSXI" in the subject line.
In the report, Mr. Dhuri writes, "The Company has also developed a novel treatment method that combines sound pressure waves with low impact exercises in warm water pools to treat arthritis patients. The treatment, called AquaSonix Therapy, helps to reduce and, in some cases, eliminate arthritis pain and restore flexibility. AquaSonix Therapy, claimed to be a breakthrough in the relevant field of medical treatments, is undergoing additional clinical research trials to provide clinical evidence for expanded medical claims.
"Given the projected high growth in patient base, huge market size in the U.S. and definitive advantages enjoyed by the products and services offered by the Company, HealthSonix appears to have a favorable market environment, required to build a successful business upon."
Beacon Equity Research Disclosure
The management and analysts contributing to this report do not currently hold any shares of HealthSonix Inc. (HSXI), though they may make open market purchases after this report has been issued. Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. The analyst(s) writing this report recognize and aspire to all of the CFA Institute Guidelines for Independent Research. Beacon Equity Research ("Beacon") certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analysts in the report. Beacon Research has been directly compensated eighteen thousand dollars directly from HealthSonix Inc. for an enrollment in its research program. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change.
13.10.06 17:49
#47
BoMa
aktueller US-Kurs
0,505, 34 % plus. Gesundheitswesen, Behandlung von Arthritis-Kranken, d.h. älteren Menschen... das wird m.e. Zukunft haben, auf jeden Fall.
13.10.06 17:50
#48
buran
Mooooooooooooooontaaaaaaag
...ich kämfe gerade mit D.B. ,wirklich kein Nerv heut für HEALTHSONIX IN.
13.10.06 18:02
#50
buran
ja sicher ,das wird
aber wenn man nur auf den Chart schaut ,wie rapide die Aktie gesunken ist und die gehandelten Stücke von nur 8.174 ,da sollte man doch erstmal vorsichtig sein

